On September 10, 2020 Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, reported that management will present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference, on Monday, September 14, 2020, at 12:30 p.m. EDT (Press release, Galectin Therapeutics, SEP 10, 2020, View Source [SID1234564957]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation may be accessed on the conference’s website at View Source or on the Company’s website www.galectintherapeutics.com. Management will also be available for one-on-one meetings with investors throughout the conference, which runs September 14 – 16, 2020.

For additional information or to schedule a one-on-one meeting with Galectin, please contact your H.C. Wainwright representative or email [email protected].